JPWO2019083350A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019083350A5 JPWO2019083350A5 JP2020543450A JP2020543450A JPWO2019083350A5 JP WO2019083350 A5 JPWO2019083350 A5 JP WO2019083350A5 JP 2020543450 A JP2020543450 A JP 2020543450A JP 2020543450 A JP2020543450 A JP 2020543450A JP WO2019083350 A5 JPWO2019083350 A5 JP WO2019083350A5
- Authority
- JP
- Japan
- Prior art keywords
- reticular
- nuclear
- cell
- ocular implant
- implant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007943 implant Substances 0.000 claims description 171
- 230000009977 dual effect Effects 0.000 claims description 53
- 210000004027 cell Anatomy 0.000 claims description 50
- 230000002792 vascular Effects 0.000 claims description 41
- 210000002808 connective tissue Anatomy 0.000 claims description 37
- 239000000463 material Substances 0.000 claims description 27
- 210000003205 muscle Anatomy 0.000 claims description 26
- 239000004626 polylactic acid Substances 0.000 claims description 21
- 230000004323 axial length Effects 0.000 claims description 15
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 12
- 239000000560 biocompatible material Substances 0.000 claims description 8
- 230000001413 cellular effect Effects 0.000 claims description 5
- 239000007769 metal material Substances 0.000 claims 2
- 239000011368 organic material Substances 0.000 claims 2
- 235000013311 vegetables Nutrition 0.000 claims 2
- 210000005056 cell body Anatomy 0.000 claims 1
- 238000000034 method Methods 0.000 description 30
- 230000010354 integration Effects 0.000 description 17
- 210000001519 tissue Anatomy 0.000 description 16
- 238000013461 design Methods 0.000 description 15
- 238000001356 surgical procedure Methods 0.000 description 15
- 210000001508 eye Anatomy 0.000 description 13
- 210000004279 orbit Anatomy 0.000 description 13
- 239000007787 solid Substances 0.000 description 13
- 239000003814 drug Substances 0.000 description 12
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 12
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 12
- 229940079593 drug Drugs 0.000 description 11
- 230000033001 locomotion Effects 0.000 description 10
- 238000005259 measurement Methods 0.000 description 10
- 238000005516 engineering process Methods 0.000 description 9
- 238000002604 ultrasonography Methods 0.000 description 8
- 230000007159 enucleation Effects 0.000 description 7
- 238000001125 extrusion Methods 0.000 description 7
- 230000008520 organization Effects 0.000 description 7
- -1 polyethylene Polymers 0.000 description 7
- 239000004698 Polyethylene Substances 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 210000005252 bulbus oculi Anatomy 0.000 description 6
- 229920000573 polyethylene Polymers 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 4
- 210000003786 sclera Anatomy 0.000 description 4
- 230000033115 angiogenesis Effects 0.000 description 3
- 230000002491 angiogenic effect Effects 0.000 description 3
- 239000012620 biological material Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000008473 connective tissue growth Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000005012 migration Effects 0.000 description 3
- 238000013508 migration Methods 0.000 description 3
- 230000003387 muscular Effects 0.000 description 3
- 230000008733 trauma Effects 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000000399 orthopedic effect Effects 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 239000013585 weight reducing agent Substances 0.000 description 2
- JJTUDXZGHPGLLC-ZXZARUISSA-N (3r,6s)-3,6-dimethyl-1,4-dioxane-2,5-dione Chemical compound C[C@H]1OC(=O)[C@H](C)OC1=O JJTUDXZGHPGLLC-ZXZARUISSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 241000552118 Cubana Species 0.000 description 1
- 241001331845 Equus asinus x caballus Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000020060 Increased inflammatory response Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 238000012084 abdominal surgery Methods 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 229910052586 apatite Inorganic materials 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003560 cancer drug Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000000642 iatrogenic effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000004579 marble Substances 0.000 description 1
- 235000008409 marco Nutrition 0.000 description 1
- 244000078446 marco Species 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000001577 neostriatum Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 235000020030 perry Nutrition 0.000 description 1
- 210000004224 pleura Anatomy 0.000 description 1
- 210000003339 pole cell Anatomy 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000007151 ring opening polymerisation reaction Methods 0.000 description 1
- 230000000707 stereoselective effect Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 230000009772 tissue formation Effects 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 230000005944 tissue migration Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2017013845A MX2017013845A (es) | 2017-10-27 | 2017-10-27 | Implante ocular duosistema multiceldas nucleoreticular. |
| MXMX/A/2017/013845 | 2017-10-27 | ||
| PCT/MX2018/000115 WO2019083350A1 (es) | 2017-10-27 | 2018-10-29 | Implante ocular duosistema multiceldas nucleoreticular |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021500214A JP2021500214A (ja) | 2021-01-07 |
| JPWO2019083350A5 true JPWO2019083350A5 (ko) | 2024-01-18 |
| JP7482781B2 JP7482781B2 (ja) | 2024-05-14 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Baino et al. | Orbital implants: State-of-the-art review with emphasis on biomaterials and recent advances | |
| CN101027016B (zh) | 软组织隔离件 | |
| Liu et al. | Porous polyethylene implant for cranioplasty and skull base reconstruction | |
| Sami et al. | Perspective on orbital enucleation implants | |
| US3849805A (en) | Bone induction in an alloplastic tray | |
| US20120226352A1 (en) | Self supporting and forming breast implant and method for forming and supporting an implant in a human body | |
| Choi et al. | Porous polyethylene channel implants: a modified porous polyethylene sheet implant designed for repairs of large and complex orbital wall fractures | |
| Grecchi et al. | Reconstruction of the zygomatic bone with smartbone®: Case report | |
| CN112107394A (zh) | 一种用于颌面骨缺损修复的植入体及其制备方法 | |
| EA028683B1 (ru) | Материал для имплантации (варианты), зубной имплантат, сосудистый имплантат и тканевый имплантат для заместительной пластики мягких тканей | |
| US11654013B2 (en) | Nucleo-reticular multi-cell dual-system eye implant | |
| JP7482781B2 (ja) | 核網様体マルチセル二重システム眼インプラント | |
| CN210962457U (zh) | 一种用于颌面骨缺损修复的植入体 | |
| RU2375007C1 (ru) | Способ замещения костных дефектов | |
| KR102240412B1 (ko) | 골반 엉덩이 성형용 보형물 | |
| JPWO2019083350A5 (ko) | ||
| KR102344360B1 (ko) | 다공성 상호 연결 구조를 갖는 코 수술용 삽입물 | |
| CN112842623A (zh) | 一种羟基磷灰石表面修饰3d生物打印可降解人工肋骨的方法 | |
| CN213552648U (zh) | 一种骨填充块 | |
| Hochberg et al. | Alloderm (Acellular Human Dermis) in Breast Reconstruction with Tissue Expansion: P6 | |
| CN215019772U (zh) | 一种中足缺损修复假体 | |
| Sami et al. | Orbital enucleation implants and ocular prostheses: Biocompatibility and design | |
| Radkevich et al. | Replacement of Temporomandibular Joint Head Using the Shape Memory Materials | |
| Sami et al. | Orbital enucleation implants: Biomaterials and design | |
| RU2269308C1 (ru) | Способ протезирования яичек при монорхизме и анорхизме |